格拉斯哥预后评分对特发性肺纤维化急性加重患者预后的意义
该回顾性研究纳入66例特发性肺纤维化急性加重住院患者,评估格拉斯哥预后评分(GPS)对死亡的预测价值。中位生存期20.7天,住院期间43.9%患者死亡;GPS-0、GPS-1、GPS-2中位总生存期分别为26.0、20.0、15.0天,GPS-0与GPS-2间差异显著(P=0.002)。多因素分析显示嗜酸性粒细胞减少(P=0.007)、较低氧合指数(P=0.014)和高GPS(P=0.006)为独立死亡预测因素。
要点
- GPS可帮助预测IPF急性加重患者住院死亡风险。
- GPS评分越高,中位总生存期越短。
- 嗜酸性粒细胞减少、低氧合指数和高GPS为独立死亡预测因素。
核心结论
- GPS有助于预测特发性肺纤维化急性加重患者的死亡风险。
研究设计与样本
- 回顾性研究,2006年1月至2016年3月在韩国天主教大学富川圣母医院进行,共登记327例住院IPF患者,最终纳入66例IPF急性加重患者。
主要发现
- 66例患者中位生存期为20.7天,住院期间29例(43.9%)死亡。
- GPS-0、GPS-1和GPS-2患者的中位总生存期分别为26.0天、20.0天和15.0天。
- GPS-0与GPS-2之间总生存期差异有统计学意义(P=0.002)。
- 多因素Cox回归分析显示,嗜酸性粒细胞减少(P=0.007)、较低氧合指数(P=0.014)和较高GPS(P=0.006)是死亡的独立预测因素。
临床怎么用
- 在IPF急性加重住院患者中,可考虑计算GPS以辅助评估死亡风险。
局限性
- 本研究为单中心回顾性研究,最终样本量较小(66例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The Glasgow prognostic score (GPS) reflects the host systemic inflammatory response and is a validated independent prognostic factor in lung cancer. We investigated GPS as a potential predictive factor of clinical outcomes in idiopathic pulmonary fibrosis (IPF) patients with acute exacerbation (AE). METHODS: This was a retrospective study performed between January 2006 and March 2016 in Bucheon St. Mary's Hospital, The Catholic University of Korea. Overall, 327 admitted IPF patients were registered in the study. Patients with definite pneumonia at the time of admission, those with left-sided heart failure, pulmonary embolism and an identifiable cause of acute lung injury, and those whose albumin or C-reactive protein levels were not measured were excluded. RESULTS: A total of 66 patients hospitalized with IPF-AE were finally included. Median survival was 20.7 days and 29 (43.9%) patients died during hospitalization. The median length of overall survival (OS) was 26.0, 20.0 and 15.0 days for GPS-0, GPS-1 and GPS-2, respectively. There were significant differences in OS between GPS-0 and GPS-2 (P = 0.002). In a multivariate analysis performed using a Cox regression model, eosinopenia (P = 0.007), lower partial pressure of oxygen/fraction of inspired oxygen ratio (P = 0.014), and higher GPS (P = 0.006) were independent predictors of mortality. CONCLUSION: GPS can be helpful in predicting mortality in IPF patients with AE.
引用
- Kang HS, Cho KW, Kwon SS, et al. Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respirology. 2017. PMID: 29024319. doi:10.1111/resp.13184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。